H.J. Thurston

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim Papp, Richard G. Langley, Bárður Sigurgeirsson et al. · British Journal of Dermatology · 2012 · 356 citations

Efficacy and Tolerability of Vildagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy

Matthew M. Goodman, H.J. Thurston, J.C. Penman · Hormone and Metabolic Research · 2009 · 73 citations

Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis

Alan Kivitz, S. Nayiager, T. Schimansky et al. · Alimentary Pharmacology & Therapeutics · 2004 · 61 citations · Full text

Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout

R. Willburger, Eduardo Mysler, J. Derbot et al. · Lara D. Veeken · 2007 · 61 citations · Full text

First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]

Ralf H Wittenberg, Ernest Schell, Gerhard Krehan et al. · Arthritis Research & Therapy · 2006 · 28 citations · Full text